{
  "directed": true,
  "graph": {
    "annotation_curie": [],
    "annotation_list": {},
    "annotation_miriam": [],
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno"
    },
    "document_metadata": {
      "authors": "Sandra Spalek",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2019 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "Discriminative Stimulus Properties of S(−)-Nicotine: “A Drug for All Seasons",
      "version": "1.0.0"
    },
    "namespace_pattern": {
      "PUBCHEM": "^\\d+$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/chebi-names.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc.genefamily-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/mesh-names.belns"
    },
    "path": "anatabine/rosecrans2017.bel",
    "pybel_version": "0.15.3"
  },
  "links": [
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Adrenal Glands",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "For example, immediately after exposure to nicotine, there is a “stimulant-kick” caused, in part, by its stimulation of the adrenal glands and resultant discharge of epinephrine (adrenaline)",
      "key": "cc638e389699058b4296c84b825a26a7",
      "line": 79,
      "relation": "increases",
      "source": 14,
      "target": 18,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Adrenal Glands",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "For example, immediately after exposure to nicotine, there is a “stimulant-kick” caused, in part, by its stimulation of the adrenal glands and resultant discharge of epinephrine (adrenaline)",
      "key": "2279f133ac05f3a96cd9092414655ed5",
      "line": 80,
      "relation": "increases",
      "source": 14,
      "target": 9,
      "target_modifier": {
        "effect": {
          "fromLoc": {
            "identifier": "0005622",
            "name": "intracellular",
            "namespace": "go"
          },
          "toLoc": {
            "identifier": "0005615",
            "name": "extracellular space",
            "namespace": "go"
          }
        },
        "modifier": "Translocation"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Pancreas",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "Nicotine also suppresses insulin output from the pancreas, which indicates that smokers are usually hyperglycemic (higher blood sugar level)",
      "key": "d23b5000310be9ee9931e572622a24c1",
      "line": 96,
      "relation": "decreases",
      "source": 14,
      "target": 5,
      "target_modifier": {
        "effect": {
          "fromLoc": {
            "identifier": "0005622",
            "name": "intracellular",
            "namespace": "go"
          },
          "toLoc": {
            "identifier": "0005615",
            "name": "extracellular space",
            "namespace": "go"
          }
        },
        "modifier": "Translocation"
      }
    },
    {
      "annotations": {
        "Anatomy": [
          {
            "identifier": "brain",
            "namespace": "Anatomy"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "Centrally, (-)-nicotine has affinity for all brain nAChR subtypes, but binds preferentially and with high affinity to α4β2 nAChRs (e.g., [12, 13])",
      "key": "a86791773d8f5567457f47b8a775fa79",
      "line": 105,
      "relation": "association",
      "source": 14,
      "target": 43
    },
    {
      "key": "56d83c1c85088922aab456fe88c1cbf6",
      "relation": "partOf",
      "source": 14,
      "target": 40
    },
    {
      "annotations": {
        "Anatomy": [
          {
            "identifier": "brain",
            "namespace": "Anatomy"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "Centrally, (-)-nicotine has affinity for all brain nAChR subtypes, but binds preferentially and with high affinity to α4β2 nAChRs (e.g., [12, 13])",
      "key": "91b59cb0e378f1925452f1cbc5092387",
      "line": 106,
      "relation": "increases",
      "source": 14,
      "target": 40
    },
    {
      "annotations": {
        "Anatomy": [
          {
            "identifier": "brain",
            "namespace": "Anatomy"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "(-)-Nicotine activates all brain nAChR subtypes, but binds preferentially and with high affinity to α4β2 nAChRs (e.g., [12])",
      "key": "b657d5651576c6d3c5cc619886bc12d5",
      "line": 191,
      "relation": "increases",
      "source": 14,
      "target": 40
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Brain",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "Moreover, (-)-nicotine (indirectly) can produce a release of dopamine in brain regions that are thought to control pleasure and motivation; dopamine is thought to underlie the pleasurable sensations experienced by smokers (e.g., [14, 15] but see [16]).",
      "key": "c146102e85a6456e43651c25f4d3693e",
      "line": 115,
      "relation": "increases",
      "source": 14,
      "target": 11,
      "target_modifier": {
        "effect": {
          "fromLoc": {
            "identifier": "0005622",
            "name": "intracellular",
            "namespace": "go"
          },
          "toLoc": {
            "identifier": "0005615",
            "name": "extracellular space",
            "namespace": "go"
          }
        },
        "modifier": "Translocation"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Nucleus Accumbens",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "For example, (-)-nicotine may increase dopamine activity at some brain sites such as the nucleus accumbens, an area thought to be important to drugs of abuse (e.g., [14, 101, 102]; but see [16, 103])",
      "key": "d5ff6d82ccbc8248302b1efc4bc25706",
      "line": 200,
      "relation": "increases",
      "source": 14,
      "target": 11,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "9989",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "For example, in rodents, administration of low doses of nicotine produced increased motor activity whereas high doses produced decreased motor activity (e.g.,[17, 18])",
      "key": "b91073e6f86df61152f3f392d4912333",
      "line": 127,
      "relation": "negativeCorrelation",
      "source": 14,
      "target": 51
    },
    {
      "key": "995315c886108b2c25bffee21b67c639",
      "relation": "partOf",
      "source": 14,
      "target": 30
    },
    {
      "key": "021650bf0caf43b307d532629af8f371",
      "relation": "partOf",
      "source": 14,
      "target": 39
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": ". It is now well established that nicotine binds to nicotinic acetylcholine receptors (nAChRs) at the cellular level and is the prototype drug used to classify nAChRs",
      "key": "7cdbb46a821dbcf285bdd58dbbce3955",
      "line": 183,
      "relation": "increases",
      "source": 14,
      "target": 39
    },
    {
      "annotations": {
        "Anatomy": [
          {
            "identifier": "brain",
            "namespace": "Anatomy"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "(-)-Nicotine activates all brain nAChR subtypes, but binds preferentially and with high affinity to α4β2 nAChRs (e.g., [12])",
      "key": "50e1b6d7d869b53d37f51f40223322ab",
      "line": 190,
      "relation": "increases",
      "source": 14,
      "target": 46,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "In antagonism tests, (-)-nicotine failed to block the stimulus effects of mecamylamine",
      "key": "d7e78a05656315a0add7e900c7f09095",
      "line": 312,
      "relation": "causesNoChange",
      "source": 14,
      "target": 8,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": ". It should be noted that hexamethonium, at relatively low doses, does not block the stimulus effects of (-)-nicotine but when administered at high doses has occasionally been reported to attenuate nicotine-like responding; probably the result of penetration into the CNS of a small proportion of the administered dose of drug (e.g., [35, 38, 64, 106, 146])",
      "key": "e11973e9a284eaa285da3180caf74b61",
      "line": 323,
      "relation": "negativeCorrelation",
      "source": 14,
      "source_modifier": {
        "modifier": "Activity"
      },
      "target": 7
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Adrenal Glands",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "The release of epinephrine stimulates the body and causes a sudden release of glucose as well as an increase in blood pressure, respiration, and heart rate",
      "key": "ae6ccc2b9e8817d0332781974a91a7c7",
      "line": 86,
      "relation": "increases",
      "source": 9,
      "source_modifier": {
        "effect": {
          "fromLoc": {
            "identifier": "0005622",
            "name": "intracellular",
            "namespace": "go"
          },
          "toLoc": {
            "identifier": "0005615",
            "name": "extracellular space",
            "namespace": "go"
          }
        },
        "modifier": "Translocation"
      },
      "target": 12,
      "target_modifier": {
        "effect": {
          "fromLoc": {
            "identifier": "0005622",
            "name": "intracellular",
            "namespace": "go"
          },
          "toLoc": {
            "identifier": "0005615",
            "name": "extracellular space",
            "namespace": "go"
          }
        },
        "modifier": "Translocation"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Adrenal Glands",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "The release of epinephrine stimulates the body and causes a sudden release of glucose as well as an increase in blood pressure, respiration, and heart rate",
      "key": "d7d5465b0124e028d2c46348840c97d0",
      "line": 87,
      "relation": "increases",
      "source": 9,
      "source_modifier": {
        "effect": {
          "fromLoc": {
            "identifier": "0005622",
            "name": "intracellular",
            "namespace": "go"
          },
          "toLoc": {
            "identifier": "0005615",
            "name": "extracellular space",
            "namespace": "go"
          }
        },
        "modifier": "Translocation"
      },
      "target": 49
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Adrenal Glands",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "The release of epinephrine stimulates the body and causes a sudden release of glucose as well as an increase in blood pressure, respiration, and heart rate",
      "key": "05634deeabbef967f018ab5ae29c25aa",
      "line": 88,
      "relation": "increases",
      "source": 9,
      "source_modifier": {
        "effect": {
          "fromLoc": {
            "identifier": "0005622",
            "name": "intracellular",
            "namespace": "go"
          },
          "toLoc": {
            "identifier": "0005615",
            "name": "extracellular space",
            "namespace": "go"
          }
        },
        "modifier": "Translocation"
      },
      "target": 34
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Adrenal Glands",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "The release of epinephrine stimulates the body and causes a sudden release of glucose as well as an increase in blood pressure, respiration, and heart rate",
      "key": "27af91a833b339b213398b0edabe3a91",
      "line": 89,
      "relation": "increases",
      "source": 9,
      "source_modifier": {
        "effect": {
          "fromLoc": {
            "identifier": "0005622",
            "name": "intracellular",
            "namespace": "go"
          },
          "toLoc": {
            "identifier": "0005615",
            "name": "extracellular space",
            "namespace": "go"
          }
        },
        "modifier": "Translocation"
      },
      "target": 37
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "Nicotine also suppresses insulin output from the pancreas, which indicates that smokers are usually hyperglycemic (higher blood sugar level)",
      "key": "96245f4bfe447f3354792b01b501b5cc",
      "line": 98,
      "relation": "increases",
      "source": 67,
      "target": 19
    },
    {
      "annotations": {
        "Anatomy": [
          {
            "identifier": "brain",
            "namespace": "Anatomy"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "Centrally, (-)-nicotine has affinity for all brain nAChR subtypes, but binds preferentially and with high affinity to α4β2 nAChRs (e.g., [12, 13])",
      "key": "ab783396b36db4fcb6ea601fc976552f",
      "line": 105,
      "relation": "association",
      "source": 43,
      "target": 14
    },
    {
      "key": "26773a5f3ca0c4a1302a06b74befc98d",
      "relation": "partOf",
      "source": 44,
      "target": 43
    },
    {
      "key": "6fc3fbf017e49ed1986855d7f0d9a4c9",
      "relation": "partOf",
      "source": 26,
      "target": 40
    },
    {
      "key": "35120c2b903ab81f8137a9a29fd8b20d",
      "relation": "partOf",
      "source": 26,
      "target": 41
    },
    {
      "key": "939ca8605b3f98034f79d216151d6006",
      "relation": "partOf",
      "source": 26,
      "target": 38
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Brain",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "Moreover, (-)-nicotine (indirectly) can produce a release of dopamine in brain regions that are thought to control pleasure and motivation; dopamine is thought to underlie the pleasurable sensations experienced by smokers (e.g., [14, 15] but see [16]).",
      "key": "0b5b813b971ae1a99de9399dca1ec3e9",
      "line": 116,
      "relation": "regulates",
      "source": 11,
      "target": 65
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Brain",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "Moreover, (-)-nicotine (indirectly) can produce a release of dopamine in brain regions that are thought to control pleasure and motivation; dopamine is thought to underlie the pleasurable sensations experienced by smokers (e.g., [14, 15] but see [16]).",
      "key": "36927ec5a24aec664dec6ded217e34d8",
      "line": 117,
      "relation": "regulates",
      "source": 11,
      "target": 64
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "9989",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "For example, in rodents, administration of low doses of nicotine produced increased motor activity whereas high doses produced decreased motor activity (e.g.,[17, 18])",
      "key": "7951db6312e1e4af47a248822056e2f3",
      "line": 127,
      "relation": "negativeCorrelation",
      "source": 51,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10116",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "In comparison, S(-)-nicotine was shown to be 7 times more toxic than R(+)-nicotine in rats injected intravenously",
      "key": "f91d7d102436b519948f11aff07e29a7",
      "line": 136,
      "relation": "increases",
      "source": 4,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10116",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "In comparison, S(-)-nicotine was shown to be 7 times more toxic than R(+)-nicotine in rats injected intravenously",
      "key": "71dd2d52f08c4a5bcadc781d97f1dbeb",
      "line": 138,
      "relation": "increases",
      "source": 4,
      "target": 61
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10116",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "In comparison, S(-)-nicotine was shown to be 7 times more toxic than R(+)-nicotine in rats injected intravenously",
      "key": "557dc2f5ed723f58d831120085f0f876",
      "line": 137,
      "relation": "increases",
      "source": 2,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10116",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "In comparison, S(-)-nicotine was shown to be 7 times more toxic than R(+)-nicotine in rats injected intravenously",
      "key": "27b7df3cd19d86d4aa3782367e6310ad",
      "line": 139,
      "relation": "increases",
      "source": 2,
      "target": 61
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "Lastly, S(-)-nornicotine is a minor metabolite of nicotine and, as mentioned previously, is considered a minor alkaloid of tobacco (Fig. 2)",
      "key": "1d24e40fd97fd220d5e33088af3e468a",
      "line": 176,
      "relation": "isA",
      "source": 30,
      "target": 15
    },
    {
      "key": "404aa30bb5e575484674ec05021dc2db",
      "relation": "partOf",
      "source": 6,
      "target": 30
    },
    {
      "key": "0561d7fc8b6a4a21a1b54fe5a0d40bfc",
      "relation": "partOf",
      "source": 15,
      "target": 30
    },
    {
      "key": "ad633c7e7aa4c8017c8f1b4b1133c4f2",
      "relation": "partOf",
      "source": 3,
      "target": 30
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "In the body, nicotine is extensively metabolized and is susceptible to a significant first-pass effect during which 80–90% of it is metabolized by the liver. Also, the lung is able to metabolize nicotine, but to a much lesser degree [78, 79]. ",
      "key": "dbaa61684d49cbc2c8fdeaff3b394d84",
      "line": 157,
      "relation": "increases",
      "source": 28,
      "target": 35
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "9606",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": " In humans, about 70–80% of nicotine is converted to the primary metabolite (-)-cotinine, a lactam derivative (Fig. 2).",
      "key": "c2afd07aa984386b295ee8391ab550bd",
      "line": 166,
      "relation": "increases",
      "source": 35,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "Lastly, S(-)-nornicotine is a minor metabolite of nicotine and, as mentioned previously, is considered a minor alkaloid of tobacco (Fig. 2)",
      "key": "8b2bba1232beb73967d24ec9f673677f",
      "line": 175,
      "relation": "increases",
      "source": 35,
      "target": 15
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "In the body, nicotine is extensively metabolized and is susceptible to a significant first-pass effect during which 80–90% of it is metabolized by the liver. Also, the lung is able to metabolize nicotine, but to a much lesser degree [78, 79]. ",
      "key": "daef379d25e14fc6e403f0f879325c55",
      "line": 158,
      "relation": "increases",
      "source": 29,
      "target": 35
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "9606",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": " In humans, about 70–80% of nicotine is converted to the primary metabolite (-)-cotinine, a lactam derivative (Fig. 2).",
      "key": "70c541adf4b2b389b4430b0219c5a27e",
      "line": 165,
      "relation": "isA",
      "source": 0,
      "target": 13
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "9606",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": " In humans, about 70–80% of nicotine is converted to the primary metabolite (-)-cotinine, a lactam derivative (Fig. 2).",
      "key": "ec6756653ce2425b26e58a33a3d81f5f",
      "line": 167,
      "relation": "association",
      "source": 0,
      "target": 13
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "9606",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": " In humans, about 70–80% of nicotine is converted to the primary metabolite (-)-cotinine, a lactam derivative (Fig. 2).",
      "key": "8d96f7950273b2f808a21af3ba25034f",
      "line": 167,
      "relation": "association",
      "source": 13,
      "target": 0
    },
    {
      "key": "a3ce0f311aec532ea5bf04e898034c53",
      "relation": "partOf",
      "source": 17,
      "target": 39
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "This conclusion is based on the fact that the stimulus effects of nicotine are convincingly blocked by (a) mecamylamine, a voltage dependent noncompetitive channel blocker at nicotinic receptors (Fig. 3; Table 4) and (b) dihydro-β-erythrodine (DHβE), a nicotinic receptor antagonist that shows high affinity for the nAChR α4β2 subunit (Fig. 3; Table 5) but not by methyllycaconitine (MLA), a α7 nicotinic receptor antagonist (Table 5).",
      "key": "8a44c91780e508798d045e6ec9835027",
      "line": 211,
      "relation": "decreases",
      "source": 8,
      "target": 14,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "This conclusion is based on the fact that the stimulus effects of nicotine are convincingly blocked by (a) mecamylamine, a voltage dependent noncompetitive channel blocker at nicotinic receptors (Fig. 3; Table 4) and (b) dihydro-β-erythrodine (DHβE), a nicotinic receptor antagonist that shows high affinity for the nAChR α4β2 subunit (Fig. 3; Table 5) but not by methyllycaconitine (MLA), a α7 nicotinic receptor antagonist (Table 5).",
      "key": "6ea4300368a3162535efbbe071cd6bbe",
      "line": 212,
      "relation": "decreases",
      "source": 8,
      "target": 21,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "For example, some biochemical studies suggest that mecamylamine is a channel blocker that inhibits most neuronal nAChRs (e.g., [131–133]).",
      "key": "46e8a4c02edc298c3cfdfd2da637bb4f",
      "line": 256,
      "relation": "decreases",
      "source": 8,
      "target": 21,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Cell": [
          {
            "identifier": "ganglion interneuron",
            "namespace": "Cell"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "Mecamylamine (Inversine®, Vecamyl®; Fig. 3) was developed over 60 years ago and marketed as a ganglionic blocker for the treatment of hypertension (e.g., [127])",
      "key": "8607b003593cf4ad2ec2b681c90fdd58",
      "line": 224,
      "relation": "decreases",
      "source": 8,
      "target": 63
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": " In addition, mecamylamine can produce CNS effects that include tremor, mental confusion, seizures, mania, and depression but the mechanisms by which these effects are produced are unclear",
      "key": "a49d802b1ceec4061f56c6c954aa0c08",
      "line": 232,
      "relation": "increases",
      "source": 8,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": " In addition, mecamylamine can produce CNS effects that include tremor, mental confusion, seizures, mania, and depression but the mechanisms by which these effects are produced are unclear",
      "key": "48bc82b4f59607ad524b3fedb888b351",
      "line": 233,
      "relation": "increases",
      "source": 8,
      "target": 59
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": " In addition, mecamylamine can produce CNS effects that include tremor, mental confusion, seizures, mania, and depression but the mechanisms by which these effects are produced are unclear",
      "key": "e3ce636335137d2df5747b25701b4124",
      "line": 234,
      "relation": "increases",
      "source": 8,
      "target": 66
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": " In addition, mecamylamine can produce CNS effects that include tremor, mental confusion, seizures, mania, and depression but the mechanisms by which these effects are produced are unclear",
      "key": "10a38785443b4baf0efb9faf145da3a9",
      "line": 235,
      "relation": "increases",
      "source": 8,
      "target": 48
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": " In addition, mecamylamine can produce CNS effects that include tremor, mental confusion, seizures, mania, and depression but the mechanisms by which these effects are produced are unclear",
      "key": "9ca745a7ef4fb227c1faa961769f1046",
      "line": 236,
      "relation": "increases",
      "source": 8,
      "target": 62
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "Biochemical and pharmacological studies have characterized mecamylamine as a nonselective, voltage dependent and noncompetitive receptor antagonist of neuronal nAChRs and it is often referred to as a “nicotine receptor antagonist.”",
      "key": "dc93383a3bc4c5c87c0b8a9511bea140",
      "line": 251,
      "relation": "decreases",
      "source": 8,
      "target": 46,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "This conclusion is based on the fact that the stimulus effects of nicotine are convincingly blocked by (a) mecamylamine, a voltage dependent noncompetitive channel blocker at nicotinic receptors (Fig. 3; Table 4) and (b) dihydro-β-erythrodine (DHβE), a nicotinic receptor antagonist that shows high affinity for the nAChR α4β2 subunit (Fig. 3; Table 5) but not by methyllycaconitine (MLA), a α7 nicotinic receptor antagonist (Table 5).",
      "key": "f95d8f9df5f4edb323749b58ad102762",
      "line": 213,
      "relation": "decreases",
      "source": 27,
      "target": 14,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          },
          {
            "identifier": "10116",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "Research results summarized in Table 5 indicate that DHβE effectively blocked the stimulus effects of (-)-nicotine in rats or mice (but see exceptions reported by [120, 121]).",
      "key": "99b3759e6a59bd23f7f83f7eb6cf28fa",
      "line": 289,
      "relation": "decreases",
      "source": 27,
      "target": 14,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "key": "e26b7926233584eefd22139184e656bb",
      "relation": "partOf",
      "source": 27,
      "target": 41
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "This conclusion is based on the fact that the stimulus effects of nicotine are convincingly blocked by (a) mecamylamine, a voltage dependent noncompetitive channel blocker at nicotinic receptors (Fig. 3; Table 4) and (b) dihydro-β-erythrodine (DHβE), a nicotinic receptor antagonist that shows high affinity for the nAChR α4β2 subunit (Fig. 3; Table 5) but not by methyllycaconitine (MLA), a α7 nicotinic receptor antagonist (Table 5).",
      "key": "2a1c4247a660556394a0b3ebb20fdefe",
      "line": 214,
      "relation": "increases",
      "source": 27,
      "target": 41
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "This conclusion is based on the fact that the stimulus effects of nicotine are convincingly blocked by (a) mecamylamine, a voltage dependent noncompetitive channel blocker at nicotinic receptors (Fig. 3; Table 4) and (b) dihydro-β-erythrodine (DHβE), a nicotinic receptor antagonist that shows high affinity for the nAChR α4β2 subunit (Fig. 3; Table 5) but not by methyllycaconitine (MLA), a α7 nicotinic receptor antagonist (Table 5).",
      "key": "c3e0b51e4cb6f130bedd7b826f0af58a",
      "line": 215,
      "relation": "decreases",
      "source": 27,
      "target": 21,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "3841",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "DHβE (Fig. 3) is an alkaloid found in plant seeds of Erythrina and is a competitive nAChR receptor antagonist with a preference for neuronal β2 subtypes",
      "key": "c474f9209887ea465e000a0390b665ad",
      "line": 264,
      "relation": "decreases",
      "source": 27,
      "target": 46,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "key": "7e4e0521baea56270180697913e5918f",
      "relation": "partOf",
      "source": 27,
      "target": 42
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "3841",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "DHβE (Fig. 3) is an alkaloid found in plant seeds of Erythrina and is a competitive nAChR receptor antagonist with a preference for neuronal β2 subtypes",
      "key": "66256184da6bf1729699e75be4b7aff7",
      "line": 265,
      "relation": "increases",
      "source": 27,
      "target": 42
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "For example, DHβE (at nM concentrations) blocks α4β2 and α3β2 nAChRs but is much less potent at α3β4 and α7 nAChRs expressed in Xenopus oocytes (e.g., [134–137]).",
      "key": "8e02a1ef20bf36f37e0168316bb5e060",
      "line": 273,
      "relation": "decreases",
      "source": 27,
      "target": 24,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "For example, DHβE (at nM concentrations) blocks α4β2 and α3β2 nAChRs but is much less potent at α3β4 and α7 nAChRs expressed in Xenopus oocytes (e.g., [134–137]).",
      "key": "52475626dfe6d19a7fdef25690cb9c92",
      "line": 274,
      "relation": "decreases",
      "source": 27,
      "target": 26,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Cell": [
          {
            "identifier": "oocyte",
            "namespace": "Cell"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "262014",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "For example, DHβE (at nM concentrations) blocks α4β2 and α3β2 nAChRs but is much less potent at α3β4 and α7 nAChRs expressed in Xenopus oocytes (e.g., [134–137]).",
      "key": "be6fd6213a4bb7cf4ae30efe821959f4",
      "line": 277,
      "relation": "decreases",
      "source": 27,
      "target": 25,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Cell": [
          {
            "identifier": "oocyte",
            "namespace": "Cell"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "262014",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "For example, DHβE (at nM concentrations) blocks α4β2 and α3β2 nAChRs but is much less potent at α3β4 and α7 nAChRs expressed in Xenopus oocytes (e.g., [134–137]).",
      "key": "2045df84741eeaecec64ecebfff54f1b",
      "line": 278,
      "relation": "decreases",
      "source": 27,
      "target": 23,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "This conclusion is based on the fact that the stimulus effects of nicotine are convincingly blocked by (a) mecamylamine, a voltage dependent noncompetitive channel blocker at nicotinic receptors (Fig. 3; Table 4) and (b) dihydro-β-erythrodine (DHβE), a nicotinic receptor antagonist that shows high affinity for the nAChR α4β2 subunit (Fig. 3; Table 5) but not by methyllycaconitine (MLA), a α7 nicotinic receptor antagonist (Table 5).",
      "key": "ecf6941f5d40a1465b54b2ef7e774ba6",
      "line": 216,
      "relation": "causesNoChange",
      "source": 32,
      "target": 14,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          },
          {
            "identifier": "10116",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "Table 5 presents results of MLA/(-)-nicotine combination studies and shows that MLA failed to alter the stimulus effects of (-)-nicotine in rats or mice (but see partial antagonism reported by Quarta et al. [126])",
      "key": "37bb12926545b14d4749536c45f5c35c",
      "line": 306,
      "relation": "causesNoChange",
      "source": 32,
      "target": 14,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "This conclusion is based on the fact that the stimulus effects of nicotine are convincingly blocked by (a) mecamylamine, a voltage dependent noncompetitive channel blocker at nicotinic receptors (Fig. 3; Table 4) and (b) dihydro-β-erythrodine (DHβE), a nicotinic receptor antagonist that shows high affinity for the nAChR α4β2 subunit (Fig. 3; Table 5) but not by methyllycaconitine (MLA), a α7 nicotinic receptor antagonist (Table 5).",
      "key": "f5e0fcfe33169f0e375b4d5050bf5151",
      "line": 217,
      "relation": "decreases",
      "source": 32,
      "target": 23,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "Its biochemical pharmacology indicates that it is a relatively potent competitive receptor antagonist that is selective for α7 nAChRs (e.g., [139–141]).",
      "key": "d46b8db905b56326f5b7b04627648fef",
      "line": 297,
      "relation": "decreases",
      "source": 32,
      "target": 23,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": " Also, mecamylamine is sometimes used as an anti-addictive drug to help people stop smoking tobacco products (e.g.,[128, 129])",
      "key": "3b586906276c54661f5d17b441d1a07a",
      "line": 243,
      "relation": "decreases",
      "source": 31,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": " Also, mecamylamine is sometimes used as an anti-addictive drug to help people stop smoking tobacco products (e.g.,[128, 129])",
      "key": "c8d3cd5b812478ec25f76ea57896e9e6",
      "line": 244,
      "relation": "decreases",
      "source": 31,
      "target": 67
    },
    {
      "key": "c0b9e642bf74f6d44549c415842825dd",
      "relation": "hasMember",
      "source": 45,
      "target": 46
    },
    {
      "key": "f9b03b326a812ddb422af610af38bc8d",
      "relation": "partOf",
      "source": 45,
      "target": 42
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": ". It should be noted that hexamethonium, at relatively low doses, does not block the stimulus effects of (-)-nicotine but when administered at high doses has occasionally been reported to attenuate nicotine-like responding; probably the result of penetration into the CNS of a small proportion of the administered dose of drug (e.g., [35, 38, 64, 106, 146])",
      "key": "c92e75791a4554e9ea2229d6eeef12df",
      "line": 322,
      "relation": "increases",
      "source": 7,
      "target": 7,
      "target_modifier": {
        "effect": {
          "fromLoc": {
            "name": "extracellular region",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "Central Nervous System",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": ". It should be noted that hexamethonium, at relatively low doses, does not block the stimulus effects of (-)-nicotine but when administered at high doses has occasionally been reported to attenuate nicotine-like responding; probably the result of penetration into the CNS of a small proportion of the administered dose of drug (e.g., [35, 38, 64, 106, 146])",
      "key": "8e3ce23521d3afe9a3599bb6f05f5ae5",
      "line": 323,
      "relation": "negativeCorrelation",
      "source": 7,
      "target": 14,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "(-)-Nicotine withdrawal symptoms might begin within a few hours after the last nicotine product, and include irritability/anger/stress/anxiety, sleep disturbances, depressed mood, craving, cognitive and attention deficits, and increased appetite.",
      "key": "4cea3e680fb0231cb83b9b03bdd539e1",
      "line": 330,
      "relation": "increases",
      "source": 53,
      "target": 50
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "(-)-Nicotine withdrawal symptoms might begin within a few hours after the last nicotine product, and include irritability/anger/stress/anxiety, sleep disturbances, depressed mood, craving, cognitive and attention deficits, and increased appetite.",
      "key": "c6cae7f9fc73990491807d33c6f13237",
      "line": 331,
      "relation": "increases",
      "source": 53,
      "target": 55
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "(-)-Nicotine withdrawal symptoms might begin within a few hours after the last nicotine product, and include irritability/anger/stress/anxiety, sleep disturbances, depressed mood, craving, cognitive and attention deficits, and increased appetite.",
      "key": "09931d09abf772e50dab04e6965ad201",
      "line": 332,
      "relation": "increases",
      "source": 53,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "(-)-Nicotine withdrawal symptoms might begin within a few hours after the last nicotine product, and include irritability/anger/stress/anxiety, sleep disturbances, depressed mood, craving, cognitive and attention deficits, and increased appetite.",
      "key": "e64020a8f12769ac42e93ef54577bcf6",
      "line": 333,
      "relation": "increases",
      "source": 53,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "(-)-Nicotine withdrawal symptoms might begin within a few hours after the last nicotine product, and include irritability/anger/stress/anxiety, sleep disturbances, depressed mood, craving, cognitive and attention deficits, and increased appetite.",
      "key": "4c0d3e434bd28c76dc55807af0c59726",
      "line": 334,
      "relation": "increases",
      "source": 53,
      "target": 52
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "(-)-Nicotine withdrawal symptoms might begin within a few hours after the last nicotine product, and include irritability/anger/stress/anxiety, sleep disturbances, depressed mood, craving, cognitive and attention deficits, and increased appetite.",
      "key": "67721c2e3e4b80d829ae12faa806d564",
      "line": 335,
      "relation": "increases",
      "source": 53,
      "target": 62
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "(-)-Nicotine withdrawal symptoms might begin within a few hours after the last nicotine product, and include irritability/anger/stress/anxiety, sleep disturbances, depressed mood, craving, cognitive and attention deficits, and increased appetite.",
      "key": "3482d751e950a49491847863c27984e0",
      "line": 336,
      "relation": "increases",
      "source": 53,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "(-)-Nicotine withdrawal symptoms might begin within a few hours after the last nicotine product, and include irritability/anger/stress/anxiety, sleep disturbances, depressed mood, craving, cognitive and attention deficits, and increased appetite.",
      "key": "60bbab4b9bb75b31730ed12ee8ea10d4",
      "line": 337,
      "relation": "decreases",
      "source": 53,
      "target": 36
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "(-)-Nicotine withdrawal symptoms might begin within a few hours after the last nicotine product, and include irritability/anger/stress/anxiety, sleep disturbances, depressed mood, craving, cognitive and attention deficits, and increased appetite.",
      "key": "98017f154330dd53fb5ed7c472fa0b29",
      "line": 338,
      "relation": "decreases",
      "source": 53,
      "target": 58
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "(-)-Nicotine withdrawal symptoms might begin within a few hours after the last nicotine product, and include irritability/anger/stress/anxiety, sleep disturbances, depressed mood, craving, cognitive and attention deficits, and increased appetite.",
      "key": "be9cdc174022b52676e55310d4cc41af",
      "line": 339,
      "relation": "increases",
      "source": 53,
      "target": 57
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "It is prescribed as medication for the treatment of depression (Wellbutrin®) and/or as an adjunct in smoking cessation therapy (Zyban®).",
      "key": "fd52a27bb90487ee147a589246225a64",
      "line": 366,
      "relation": "association",
      "source": 53,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "Varenicline (Chantix®; Fig. 4) is prescribed as an adjunct medication in smoking cessation therapy and is thought to exert its effects as a partial agonist at α4β2 nAChRs and as a full agonist at α7 nAChRs [211, 212]. ",
      "key": "8bb3d5a2a4af45d60a33ba86b2cc6908",
      "line": 381,
      "relation": "association",
      "source": 53,
      "target": 16
    },
    {
      "key": "16df25ca300f7eb5f1770192ed171ba1",
      "relation": "partOf",
      "source": 1,
      "target": 38
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "Lobeline binds with high affinity to α4β2 nAChRs and displays mixed receptor agonist/antagonist actions (e.g., [150–154]).",
      "key": "37a30d59f1c4e5daf9cfa581a59f6e1c",
      "line": 344,
      "relation": "increases",
      "source": 1,
      "target": 38
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "Lobeline has, however, been shown to antagonize partially the stimulus effects of (-)-nicotine and S(+)-methamphetamine ([64, 160]; but see [66]).",
      "key": "0d5490eb161ad9e8339f214dfc3b98c2",
      "line": 350,
      "relation": "decreases",
      "source": 1,
      "target": 14,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "Lobeline has, however, been shown to antagonize partially the stimulus effects of (-)-nicotine and S(+)-methamphetamine ([64, 160]; but see [66]).",
      "key": "66881c7f51f298648aa16bbcfda460d0",
      "line": 351,
      "relation": "decreases",
      "source": 1,
      "target": 33,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "Bupropion [a.k.a. amfebutamone, (RS)-2-(tert-Butylamino)-1-(3-chlorophenyl)propan1-one, 3-Chloro tert-butylcathinone, 3-Chloro-N-tert-butyl-β-ketoamphetamine; Fig. 4] is a phenylaminoketone or cathinone derivative that is a weak central nervous system (CNS) stimulant",
      "key": "2196e1ba31fca730b68381f007cc8578",
      "line": 358,
      "relation": "increases",
      "source": 10,
      "target": 20,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "It is prescribed as medication for the treatment of depression (Wellbutrin®) and/or as an adjunct in smoking cessation therapy (Zyban®).",
      "key": "91ac48af511146925292bbfb3e762cae",
      "line": 365,
      "relation": "decreases",
      "source": 10,
      "target": 62
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "It is prescribed as medication for the treatment of depression (Wellbutrin®) and/or as an adjunct in smoking cessation therapy (Zyban®).",
      "key": "3faa0d6a030a7fcb0176d1ad98e79c81",
      "line": 366,
      "relation": "association",
      "source": 10,
      "target": 53
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "Other studies have reported that bupropion blocked the acute effects of (-)-nicotine in a number of behavioral assays in mice (e.g., [171, 172])",
      "key": "25d1ab84040ed1ada5ef0beb6ae4015f",
      "line": 373,
      "relation": "decreases",
      "source": 10,
      "target": 14,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "Varenicline (Chantix®; Fig. 4) is prescribed as an adjunct medication in smoking cessation therapy and is thought to exert its effects as a partial agonist at α4β2 nAChRs and as a full agonist at α7 nAChRs [211, 212]. ",
      "key": "ce7cf67ccbbd546ed4690dde4a2ea266",
      "line": 381,
      "relation": "association",
      "source": 16,
      "target": 53
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "Varenicline (Chantix®; Fig. 4) is prescribed as an adjunct medication in smoking cessation therapy and is thought to exert its effects as a partial agonist at α4β2 nAChRs and as a full agonist at α7 nAChRs [211, 212]. ",
      "key": "ec13b8a99741641d1d41ce99e780abbc",
      "line": 382,
      "relation": "increases",
      "source": 16,
      "target": 26,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "identifier": "28391535",
        "journal": "Current topics in behavioral neurosciences",
        "last": "Young R",
        "name": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "namespace": "pubmed",
        "pages": "51-94",
        "volume": "39"
      },
      "evidence": "Varenicline (Chantix®; Fig. 4) is prescribed as an adjunct medication in smoking cessation therapy and is thought to exert its effects as a partial agonist at α4β2 nAChRs and as a full agonist at α7 nAChRs [211, 212]. ",
      "key": "796358856c1d5774019b6f767e54fa2c",
      "line": 383,
      "relation": "increases",
      "source": 16,
      "target": 23,
      "target_modifier": {
        "modifier": "Activity"
      }
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"(-)-cotinine\")",
      "concept": {
        "name": "(-)-cotinine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "f5fc7e0e2379ca3e6216c182d24ece00"
    },
    {
      "bel": "a(CHEBI:\"(-)-lobeline\")",
      "concept": {
        "name": "(-)-lobeline",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "9b027d23cef4e1cbefeaf9da1946c017"
    },
    {
      "bel": "a(CHEBI:\"(R)-nicotine\")",
      "concept": {
        "name": "(R)-nicotine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "9c866190b66aa41051279f1d2204c102"
    },
    {
      "bel": "a(CHEBI:\"(S)-anabasine\")",
      "concept": {
        "name": "(S)-anabasine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "cd74d70eeec2db316be0b94f8e410605"
    },
    {
      "bel": "a(CHEBI:\"(S)-nicotine\")",
      "concept": {
        "name": "(S)-nicotine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "53625fde103c51700bdfaab77f73a4b0"
    },
    {
      "bel": "a(CHEBI:\"insulin (human)\")",
      "concept": {
        "name": "insulin (human)",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "0df48c9be952fa6758da45684b16e731"
    },
    {
      "bel": "a(CHEBI:Anatabine)",
      "concept": {
        "name": "Anatabine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "9e5ab9569cca155e199162d8c20415b4"
    },
    {
      "bel": "a(CHEBI:Hexamethonium)",
      "concept": {
        "name": "Hexamethonium",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "4db95c29da75b3fbdcc274530e543143"
    },
    {
      "bel": "a(CHEBI:Mecamylamine)",
      "concept": {
        "name": "Mecamylamine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "0a541fa62f153d4c8ae539050da2562d"
    },
    {
      "bel": "a(CHEBI:adrenaline)",
      "concept": {
        "name": "adrenaline",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "0675be36381ca8fe2f73ea4595d7f925"
    },
    {
      "bel": "a(CHEBI:bupropion)",
      "concept": {
        "name": "bupropion",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "07a219e45e304acd5f11e8863e54247b"
    },
    {
      "bel": "a(CHEBI:dopamine)",
      "concept": {
        "name": "dopamine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "4c950dc480c64069e58998401b2083c1"
    },
    {
      "bel": "a(CHEBI:glucose)",
      "concept": {
        "name": "glucose",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "8b4d8974cf8c0e5830f78bb44168cf4d"
    },
    {
      "bel": "a(CHEBI:lactam)",
      "concept": {
        "name": "lactam",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "a73771ef8c3cd5211cf10bf6b56123a7"
    },
    {
      "bel": "a(CHEBI:nicotine)",
      "concept": {
        "name": "nicotine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "44ed555f78bacda2933ddef1d4280ce9"
    },
    {
      "bel": "a(CHEBI:nornicotine)",
      "concept": {
        "name": "nornicotine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "45a019f376f56f4dfcee8306c7845db9"
    },
    {
      "bel": "a(CHEBI:varenicline)",
      "concept": {
        "name": "varenicline",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "203e34366e86a604df08edbdf990ce4b"
    },
    {
      "bel": "a(HGNCGENEFAMILY:\"Cholinergic receptors nicotinic subunits\")",
      "concept": {
        "name": "Cholinergic receptors nicotinic subunits",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Abundance",
      "id": "a192e6f3df21a6ff54adc0af95fdff63"
    },
    {
      "bel": "a(MESH:\"Adrenal Glands\")",
      "concept": {
        "name": "Adrenal Glands",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "c91d55cb7894642ded4cba46ceef23d1"
    },
    {
      "bel": "a(MESH:\"Blood Glucose\")",
      "concept": {
        "name": "Blood Glucose",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "c598ab5b75268b0b9109c60541fc59ff"
    },
    {
      "bel": "a(MESH:\"Central Nervous System\")",
      "concept": {
        "name": "Central Nervous System",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "9480f2a1fd508f09840a01c1083e635e"
    },
    {
      "bel": "a(MESH:\"Receptors, Nicotinic\")",
      "concept": {
        "name": "Receptors, Nicotinic",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "a06bdcddaf9cc29de921f81ce6f9b2e9"
    },
    {
      "bel": "a(MESH:\"Toxic Actions\")",
      "concept": {
        "name": "Toxic Actions",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "3f70d524d72b280eef1fafb12c44e1c2"
    },
    {
      "bel": "a(MESH:\"alpha7 Nicotinic Acetylcholine Receptor\")",
      "concept": {
        "name": "alpha7 Nicotinic Acetylcholine Receptor",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "58b5f9ca1e8fc58bac5d0b7c4002e2bd"
    },
    {
      "bel": "a(MESH:\"nicotinic receptor alpha3beta2\")",
      "concept": {
        "name": "nicotinic receptor alpha3beta2",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "a9483d79f2ac705a295314d0681b9d7d"
    },
    {
      "bel": "a(MESH:\"nicotinic receptor alpha3beta4\")",
      "concept": {
        "name": "nicotinic receptor alpha3beta4",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "3f639b3a4a9177da87f05730553f4849"
    },
    {
      "bel": "a(MESH:\"nicotinic receptor alpha4beta2\")",
      "concept": {
        "name": "nicotinic receptor alpha4beta2",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "a896a5b33bbe3a8801a7622bc4a82c98"
    },
    {
      "bel": "a(MESH:Dihydro-beta-Erythroidine)",
      "concept": {
        "name": "Dihydro-beta-Erythroidine",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "cbbed4bbb364874a6b8d042a44ccfc96"
    },
    {
      "bel": "a(MESH:Liver)",
      "concept": {
        "name": "Liver",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "e30cfc38f11ab042209eb4fc62bc6a02"
    },
    {
      "bel": "a(MESH:Lung)",
      "concept": {
        "name": "Lung",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "01153b8afebc21b98ee3c9ceb2b46df9"
    },
    {
      "bel": "a(MESH:Tobacco)",
      "concept": {
        "name": "Tobacco",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "95a6aa669edf3e2d116b1e43e56a8eeb"
    },
    {
      "bel": "a(PUBCHEM:4032)",
      "concept": {
        "name": "4032",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "224f40bf846307c58643948bcc8ba408"
    },
    {
      "bel": "a(PUBCHEM:5288811)",
      "concept": {
        "name": "5288811",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "7ca205ff51400232a317077eb51dfd31"
    },
    {
      "bel": "a(PUBCHEM:9306)",
      "concept": {
        "name": "9306",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "d146d09053757435ab8610d78638cc56"
    },
    {
      "bel": "bp(GO:\"cellular respiration\")",
      "concept": {
        "name": "cellular respiration",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "ced509226a10b89fb0f158c6a90c60c2"
    },
    {
      "bel": "bp(GO:\"nicotine metabolic process\")",
      "concept": {
        "name": "nicotine metabolic process",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "d1e40c1ed199249e598728c904640abd"
    },
    {
      "bel": "bp(GO:cognition)",
      "concept": {
        "name": "cognition",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "24220ec2073c35bcd945681ee9c6ea38"
    },
    {
      "bel": "bp(MESH:\"Heart Rate\")",
      "concept": {
        "name": "Heart Rate",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "04c7567a808ed8cd352b78e95310d948"
    },
    {
      "bel": "complex(a(CHEBI:\"(-)-lobeline\"), a(MESH:\"nicotinic receptor alpha4beta2\"))",
      "function": "Complex",
      "id": "e5aa4f80eb370189613eec24cce493cb",
      "members": [
        {
          "bel": "a(CHEBI:\"(-)-lobeline\")",
          "concept": {
            "name": "(-)-lobeline",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "9b027d23cef4e1cbefeaf9da1946c017"
        },
        {
          "bel": "a(MESH:\"nicotinic receptor alpha4beta2\")",
          "concept": {
            "name": "nicotinic receptor alpha4beta2",
            "namespace": "MESH"
          },
          "function": "Abundance",
          "id": "a896a5b33bbe3a8801a7622bc4a82c98"
        }
      ]
    },
    {
      "bel": "complex(a(CHEBI:nicotine), a(HGNCGENEFAMILY:\"Cholinergic receptors nicotinic subunits\"))",
      "function": "Complex",
      "id": "7515692e7617cecafe6ecbbab6912f69",
      "members": [
        {
          "bel": "a(CHEBI:nicotine)",
          "concept": {
            "name": "nicotine",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "44ed555f78bacda2933ddef1d4280ce9"
        },
        {
          "bel": "a(HGNCGENEFAMILY:\"Cholinergic receptors nicotinic subunits\")",
          "concept": {
            "name": "Cholinergic receptors nicotinic subunits",
            "namespace": "HGNCGENEFAMILY"
          },
          "function": "Abundance",
          "id": "a192e6f3df21a6ff54adc0af95fdff63"
        }
      ]
    },
    {
      "bel": "complex(a(CHEBI:nicotine), a(MESH:\"nicotinic receptor alpha4beta2\"))",
      "function": "Complex",
      "id": "ecc6d8354ea7ff3e332545f530290df0",
      "members": [
        {
          "bel": "a(CHEBI:nicotine)",
          "concept": {
            "name": "nicotine",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "44ed555f78bacda2933ddef1d4280ce9"
        },
        {
          "bel": "a(MESH:\"nicotinic receptor alpha4beta2\")",
          "concept": {
            "name": "nicotinic receptor alpha4beta2",
            "namespace": "MESH"
          },
          "function": "Abundance",
          "id": "a896a5b33bbe3a8801a7622bc4a82c98"
        }
      ]
    },
    {
      "bel": "complex(a(MESH:\"nicotinic receptor alpha4beta2\"), a(MESH:Dihydro-beta-Erythroidine))",
      "function": "Complex",
      "id": "e0d6b0287a3d5aab4ab4ca675b12c206",
      "members": [
        {
          "bel": "a(MESH:\"nicotinic receptor alpha4beta2\")",
          "concept": {
            "name": "nicotinic receptor alpha4beta2",
            "namespace": "MESH"
          },
          "function": "Abundance",
          "id": "a896a5b33bbe3a8801a7622bc4a82c98"
        },
        {
          "bel": "a(MESH:Dihydro-beta-Erythroidine)",
          "concept": {
            "name": "Dihydro-beta-Erythroidine",
            "namespace": "MESH"
          },
          "function": "Abundance",
          "id": "cbbed4bbb364874a6b8d042a44ccfc96"
        }
      ]
    },
    {
      "bel": "complex(a(MESH:Dihydro-beta-Erythroidine), p(HGNC:CHRNB2))",
      "function": "Complex",
      "id": "b32da7c77bdf595d2420e22af14bfc8e",
      "members": [
        {
          "bel": "a(MESH:Dihydro-beta-Erythroidine)",
          "concept": {
            "name": "Dihydro-beta-Erythroidine",
            "namespace": "MESH"
          },
          "function": "Abundance",
          "id": "cbbed4bbb364874a6b8d042a44ccfc96"
        },
        {
          "bel": "p(HGNC:CHRNB2)",
          "concept": {
            "name": "CHRNB2",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7e5d65d97e555667e0928696d86663e6"
        }
      ]
    },
    {
      "bel": "complex(p(GO:\"I-kappaB/NF-kappaB complex\"))",
      "function": "Complex",
      "id": "d32de53c2beff68d985e4d85c1600e7b",
      "members": [
        {
          "bel": "p(GO:\"I-kappaB/NF-kappaB complex\")",
          "concept": {
            "name": "I-kappaB/NF-kappaB complex",
            "namespace": "GO"
          },
          "function": "Protein",
          "id": "b52b99cbd49bc52ac106dec4eb636ecd"
        }
      ]
    },
    {
      "bel": "p(GO:\"I-kappaB/NF-kappaB complex\")",
      "concept": {
        "name": "I-kappaB/NF-kappaB complex",
        "namespace": "GO"
      },
      "function": "Protein",
      "id": "b52b99cbd49bc52ac106dec4eb636ecd"
    },
    {
      "bel": "p(HGNC:CHRNB2)",
      "concept": {
        "name": "CHRNB2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7e5d65d97e555667e0928696d86663e6"
    },
    {
      "bel": "p(HGNCGENEFAMILY:\"Cholinergic receptors nicotinic subunits\")",
      "concept": {
        "name": "Cholinergic receptors nicotinic subunits",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "8038209bc0b5bd919a7208d644f913f8"
    },
    {
      "bel": "path(MESH:\"Behavior, Addictive\")",
      "concept": {
        "name": "Behavior, Addictive",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "591ce7dffbbd2b437e2cca6c2e68a202"
    },
    {
      "bel": "path(MESH:\"Bipolar Disorder\")",
      "concept": {
        "name": "Bipolar Disorder",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "5e400b2946cf4f0d4eceb7d7bf8c2a0e"
    },
    {
      "bel": "path(MESH:\"Blood Pressure\")",
      "concept": {
        "name": "Blood Pressure",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "4abd0c9cfb634a6105a4d64cc5e27ed0"
    },
    {
      "bel": "path(MESH:\"Irritable Mood\")",
      "concept": {
        "name": "Irritable Mood",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "8d5a198fdb9c3be6187e936b4aec0351"
    },
    {
      "bel": "path(MESH:\"Motor Activity\")",
      "concept": {
        "name": "Motor Activity",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "f382cf35005457ced840abe2c7476ee9"
    },
    {
      "bel": "path(MESH:\"Sleep Wake Disorders\")",
      "concept": {
        "name": "Sleep Wake Disorders",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "bfc01f795624b5c78965e77b95dd72f9"
    },
    {
      "bel": "path(MESH:\"Smoking Cessation\")",
      "concept": {
        "name": "Smoking Cessation",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "83300dbb97f30192954088acd6e06bb1"
    },
    {
      "bel": "path(MESH:\"Stress, Psychological\")",
      "concept": {
        "name": "Stress, Psychological",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "0fd6cd2d5509c71efc2fae204e14e188"
    },
    {
      "bel": "path(MESH:Anger)",
      "concept": {
        "name": "Anger",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "3cb56331df51ea722b7f9973d2f70f22"
    },
    {
      "bel": "path(MESH:Anxiety)",
      "concept": {
        "name": "Anxiety",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "81296be1c4ea6bcc3d464a0a9d9342b0"
    },
    {
      "bel": "path(MESH:Appetite)",
      "concept": {
        "name": "Appetite",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "1d7640f79a070afa040ff5b9dfb2a9c4"
    },
    {
      "bel": "path(MESH:Attention)",
      "concept": {
        "name": "Attention",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "f22e7196f5d0614ad79325e3690466ec"
    },
    {
      "bel": "path(MESH:Confusion)",
      "concept": {
        "name": "Confusion",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "415f15fabd2d2a6ea9c541e58be7aa37"
    },
    {
      "bel": "path(MESH:Craving)",
      "concept": {
        "name": "Craving",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "a3602eff36e29d05ad327cceae447401"
    },
    {
      "bel": "path(MESH:Death)",
      "concept": {
        "name": "Death",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "10a8517e414b47762b224fc2cc999027"
    },
    {
      "bel": "path(MESH:Depression)",
      "concept": {
        "name": "Depression",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "4cbb9f9f3c1f12c3f20dc0eb627a8224"
    },
    {
      "bel": "path(MESH:Hypertension)",
      "concept": {
        "name": "Hypertension",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "dfc5303e42570a3507bbb51f1a445664"
    },
    {
      "bel": "path(MESH:Motivation)",
      "concept": {
        "name": "Motivation",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "f416b88d349a22135f63411787110178"
    },
    {
      "bel": "path(MESH:Pleasure)",
      "concept": {
        "name": "Pleasure",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "ecf355fb0a22c6a303937b51d238a95d"
    },
    {
      "bel": "path(MESH:Seizures)",
      "concept": {
        "name": "Seizures",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "70d77d326911c2a2fc35d764b4963e57"
    },
    {
      "bel": "path(MESH:Smoking)",
      "concept": {
        "name": "Smoking",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "421977e25516b65692cc5c7ed794a7eb"
    },
    {
      "bel": "path(MESH:Tremor)",
      "concept": {
        "name": "Tremor",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "b041fa5b6e0d8f3cda2244378dd215f7"
    }
  ]
}